GetTopicDetailResponse(id=288d114e1766, topicName=塔拉妥單抗, introduction=, content=小細胞肺癌 安進 塔拉妥單抗, image=null, comments=0, allHits=1145, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Wed May 22 14:22:32 CST 2024, time=2024-05-22, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=482120, tagList=[TagDto(tagId=482120, tagName=塔拉妥單抗)], ipAttribution=威斯康星, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2234849, encodeId=a7bd2234849a7, content=<a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小細胞肺癌#</a> <a href='/topic/show?id=6bf49e844e9' target=_blank style='color:#2F92EE;'>#阿替利珠單抗#</a> <a href='/topic/show?id=7b2910612398' target=_blank style='color:#2F92EE;'>#度伐利尤單抗#</a> <a href='/topic/show?id=b9be106e00f4' target=_blank style='color:#2F92EE;'>#斯魯利單抗#</a> <a href='/topic/show?id=404d1054e621' target=_blank style='color:#2F92EE;'>#阿得貝利單抗#</a> <a href='/topic/show?id=288d114e1766' target=_blank style='color:#2F92EE;'>#塔拉妥單抗#</a>, objectTitle=小細胞肺癌五大治療方案：3年總生存率提高2倍！, objectType=article, longId=849646, objectId=98b184964661, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20241101/31e049d98bd14d5b9cdecf7f01f104e0-gqPmhaS0ObWL.jpg, objectUrl=/article/show_article.do?id=98b184964661, replyNumber=0, likeNumber=77, createdTime=2024-11-03, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=98b184964661, moduleTitle=小細胞肺癌五大治療方案：3年總生存率提高2倍！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=98b184964661)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2223856, encodeId=188b222385600, content=<a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小細胞肺癌#</a> <a href='/topic/show?id=288d114e1766' target=_blank style='color:#2F92EE;'>#塔拉妥單抗#</a>, objectTitle=劍指小細胞肺癌，塔拉妥單抗臨床療效數(shù)據(jù)更新，腦轉(zhuǎn)移灶也大比例縮?。? objectType=article, longId=841060, objectId=237184106059, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720669414779_5579292.png, objectUrl=/article/show_article.do?id=237184106059, replyNumber=0, likeNumber=115, createdTime=2024-09-03, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=237184106059, moduleTitle=劍指小細胞肺癌，塔拉妥單抗臨床療效數(shù)據(jù)更新，腦轉(zhuǎn)移灶也大比例縮??！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=237184106059)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2217560, encodeId=d294221e5600b, content=<a href='/topic/show?id=3e7f491e23e' target=_blank style='color:#2F92EE;'>#廣泛期小細胞肺癌#</a> <a href='/topic/show?id=288d114e1766' target=_blank style='color:#2F92EE;'>#塔拉妥單抗#</a>, objectTitle=讀書報告 | DeLLphi-301研究：塔拉妥單抗后線治療廣泛期小細胞肺癌, objectType=article, longId=836667, objectId=46d583666ef2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240729/1722218236645_8538692.jpg, objectUrl=/article/show_article.do?id=46d583666ef2, replyNumber=0, likeNumber=90, createdTime=2024-07-30, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=46d583666ef2, moduleTitle=讀書報告 | DeLLphi-301研究：塔拉妥單抗后線治療廣泛期小細胞肺癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=46d583666ef2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2206002, encodeId=684d2206002ad, content=<a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小細胞肺癌#</a> <a href='/topic/show?id=33b645836cf' target=_blank style='color:#2F92EE;'>#安進#</a> <a href='/topic/show?id=288d114e1766' target=_blank style='color:#2F92EE;'>#塔拉妥單抗#</a>, objectTitle=FDA批準(zhǔn)安進公司小細胞肺癌劃時代治療藥物——Imdelltra（tarlatamab）上市, objectType=article, longId=827037, objectId=f1b582e03716, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240511/38d053b9c738411e9228f3a4fb7cd6ea-DWgoJ5Xeou5v.jpg, objectUrl=/article/show_article.do?id=f1b582e03716, replyNumber=0, likeNumber=142, createdTime=2024-05-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=f1b582e03716, moduleTitle=FDA批準(zhǔn)安進公司小細胞肺癌劃時代治療藥物——Imdelltra（tarlatamab）上市, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f1b582e03716)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-05-22發(fā)表于威斯康星
